Diabetes Atherosclerosis Intervention Study (DAIS)
(Redirected from Diabetes Atherosclerosis Intervention Study)
|
High Density Lipoprotein Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Clinical Trials |
|
Case Studies |
|
Diabetes Atherosclerosis Intervention Study (DAIS) On the Web |
|
American Roentgen Ray Society Images of Diabetes Atherosclerosis Intervention Study (DAIS) |
|
Diabetes Atherosclerosis Intervention Study (DAIS) in the news |
|
Risk calculators and risk factors for Diabetes Atherosclerosis Intervention Study (DAIS) |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]
Overview
The Diabetes Atherosclerosis Intervention Study (DAIS) is a double-blinded placebo-controlled study that assessed the rate of cardiovascular disease following the administration of 200 mg fenofibrate in non-insulin-dependent diabetes subjects.[1]
References
- ↑ Steiner G (1996). "The Diabetes Atherosclerosis Intervention Study (DAIS): a study conducted in cooperation with the World Health Organization. The DAIS Project Group". Diabetologia. 39 (12): 1655–61. PMID 9081851.